Author: Ravi Shankar

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS.

LONDON, Oct. 21, 2026 (GLOBE NEWSWIRE) — Pulsar Helium Inc. (AIM: PLSR, TSXV: PLSR, OTCQB: PSRHF) (“Pulsar” or the “Company”), a primary helium company, is pleased to report that in the most recent edition of CBS’s “60 Minutes” that aired Sunday, October 18, 2026, Cliff Cain, Pulsar’s President, was interviewed on the show as a helium expert. The segment related to the impact of the helium supply shortage principally caused by the conflict in the Persian Gulf area and the closure of the Strait of Hormuz, which has stranded the supply of helium from Qatar. Mr. Cain gave the interview on Pulsar’s Topaz Project in front of Jetstream 1 and allowed the CBS interviewer to demonstrate the flow of gas from one of the Company’s wells. Mr. Cain, has briefed policy majors at the U.S. Pentagon on the worrisome helium supply, advised that he has consistently warned that the complicated helium supply chain was vulnerable to disruption. Mr. Cain noted that “the constrained helium supply may affect weapons development, since it’s needed for making fiber optics, munitions and electronics.”

The CBS “60 Minutes” segment, “Helium, key for semiconductor manufacturing and medical equipment, faces shortage | 60 minutes” can be viewed on the following CBS Link.

On behalf of Pulsar Helium Inc.
“Thomas Abraham-James”
CEO and Director

Further Information:

Pulsar Helium Inc.
connect@pulsarhelium.com
+ 1 (218) 203-5301 (USA/Canada)
+44 (0)2033 55 9889 (United Kingdom)
https://pulsarhelium.com
https://ca.linkedin.com/company/pulsar-helium-inc.

Strand Hanson Limited
(Nominated & Financial Adviser, and Broker)
Ritchie Balmer / Rob Patrick
+44 (0) 207 409 3494

Yellow Jersey PR Limited
(Financial Public Relations)
Charles Goodwin / Annabelle Wills
+44 777 5194 357
pulsarhelium@yellowjerseypr.com

About Pulsar Helium Inc.

Pulsar Helium Inc. is a publicly traded company quoted on the AIM market of the London Stock Exchange (United Kingdom) and listed on the TSX Venture Exchange with the ticker PLSR (Canada), as well as on the OTCQB with the ticker PSRHF (United States of America). Pulsar’s portfolio consists of its flagship Topaz helium project in Minnesota, the Falcon project in Michigan (both in the USA), and the Tunu helium project in Greenland. Pulsar is the first mover in both locations with primary helium occurrences not associated with the production of hydrocarbons identified at each.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Following an on-site inspection, Finantsinspektsioon (the Estonian Financial Supervision and Resolution Authority) issued a precept requiring Coop Pank to improve its governance, internal control, risk management, regulatory reporting and lending procedures. The bank agrees with the findings and will implement the required changes within the deadlines set out in the precept in 2026 and 2027.

During the inspection, Finantsinspektsioon assessed the bank’s overall governance, internal control and risk management functions, regulatory reporting and responsible lending practices. The findings concern the organisation of governance and internal control functions, the management of operational, IT, credit and interest rate risks, supervisory reporting and lending procedures.

According to Heikko Mäe, Member of the Management Board and Chief Risk Officer of Coop Pank, the bank has already started implementing the necessary changes.

“We are working closely with Finantsinspektsioon and will implement the required changes within the agreed deadlines. We are strengthening our control functions and improving our internal rules, processes and IT systems. To date, the bank has already approved an ESG policy, updated its market risk management policy and expanded the range of scenarios used in market risk stress testing. The remaining changes will be implemented in stages, and the bank will submit supporting documentation to Finantsinspektsioon to demonstrate compliance with the requirements,” said Mäe.

“The bank has grown rapidly in recent years, and supervisory expectations towards us have increased accordingly. The findings of Finantsinspektsioon mainly concern how we have structured our internal operations and procedures, as well as the level of detail with which we document and justify our day-to-day decisions. We take these findings seriously, as sound risk management is the foundation of a bank’s trustworthiness,” added Heikko Mäe.

The precept does not affect the bank’s day-to-day operations or customer service and has no impact on the bank’s financial results reported to date.

Coop Pank, based on Estonian capital, is one of the five universal banks operating in Estonia. The bank has 240,600 everyday banking customers. Coop Pank leverages the synergies between retail and banking to bring everyday banking services closer to where people live.

Additional information:

Kristjan Seema
Head of Marketing and Communications
Coop Pank AS
Tel: +372 5505 253
kristjan.seema@cooppank.ee

21 October 2026

Transaction in own shares

Admiral Group plc (the “Company”) announces that for the period 14 October 2026 to 20 October 2026 it has purchased for cancellation 250,000 of its ordinary shares of 0.1 pence each (‘ordinary shares’), as detailed below, through the Company’s broker UBS AG, London Branch (“UBS“) as part of its buy-back announced on 30 September 2026.

Date of Purchase	Number of Ordinary share purchased	Volume weighted average price (pence)	Highest Price per share	Lowest Price per share	Trading venue
14 October 2026	22,000	3,676.7718	3,692.00	3,652.00	London Stock Exchange
14 October 2026	19,000	3,676.2052	3,692.00	3,634.00	BATS Europe
14 October 2026	6,000	3,678.4820	3,700.00	3,662.00	Chi-X Europe
14 October 2026	3,000	3,674.1953	3,688.00	3,654.00	Aquis
15 October 2026	22,000	3,745.4965	3,776.00	3,714.00	London Stock Exchange
15 October 2026	19,000	3,745.3772	3,776.00	3,708.00	BATS Europe
15 October 2026	6,000	3,743.5130	3,770.00	3,716.00	Chi-X Europe
15 October 2026	3,000	3,747.5193	3,768.00	3,726.00	Aquis
16 October 2026	22,000	3,773.0743	3,800.00	3,734.00	London Stock Exchange
16 October 2026	19,000	3,773.7068	3,800.00	3,734.00	BATS Europe
16 October 2026	6,000	3,772.8340	3,798.00	3,734.00	Chi-X Europe
16 October 2026	3,000	3,773.5093	3,798.00	3,746.00	Aquis
19 October 2026	21,000	3,768.9113	3,800.00	3,746.00	London Stock Exchange
19 October 2026	19,000	3,769.7044	3,800.00	3,746.00	BATS Europe
19 October 2026	7,000	3,769.5151	3,800.00	3,746.00	Chi-X Europe
19 October 2026	3,000	3,770.5400	3,800.00	3,752.00	Aquis
20 October 2026	22,000	3,729.0738	3,766.00	3,688.00	London Stock Exchange
20 October 2026	19,000	3,733.1585	3,766.00	3,688.00	BATS Europe
20 October 2026	6,000	3,733.0960	3,766.00	3,696.00	Chi-X Europe
20 October 2026	3,000	3,734.2513	3,758.00	3,702.00	Aquis

The Company intends to cancel all of the purchased ordinary shares.

Following the cancellation of the repurchased shares reported above, the Company’s issued share capital will consist of 305,554,676 ordinary shares with voting rights.

There are no ordinary shares held in Treasury.

The above figure (305,554,676) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.

From the commencement of the share buy-back programme on 30 September 2026, the Company has purchased 750,000 ordinary shares in aggregate at a weighted average price of 3,670.50p per ordinary share.

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended, a full breakdown of the individual purchases of ordinary shares made by UBS on behalf of the Company can be found in the link to this announcement.

Admiral weekly share purchases 14.10.26 – 20.10.26

– ENDS –

For further information, please contact:

Media:        
Addy Frederick                            Addy.Frederick@admiralgroup.co.uk

Investors/ Analysts:        
Jelena Bjelanovic                        investorrelationssupport@admiralgroup.co.uk

Attachment

• Admiral weekly share purchases 14.10.26 – 20.10.26

Company Announcement No. 1175

Continuing earnings growth in Air & Sea and Contract Logistics and operational recovery in the Road division

• DSV reported EBIT before special items of DKK 6,606 million for Q3 2026, of which DKK 300 million were gains from property disposals. Diluted adjusted earnings per share increased 11.5% to DKK 56.1 in Q3 2026, driven by positive performance in the Air & Sea and Contract Logistics divisions.
• The Road division was impacted by lower productivity and negative volume growth related to operational issues in Europe following the Schenker integration; however, operations normalised towards the end of the quarter.
• The Schenker integration generally continued as planned, and we maintain our expectation of annual synergies at the level of DKK 9 billion, partly offset by inflationary pressure and costs related to increased activity in Contract Logistics. The remaining synergies related to Road and certain Group functions are expected to be delayed into 2027 due to operational issues in Road.
• The adjusted free cash flow came to DKK 6,439 million for Q3 2026, corresponding to an adjusted cash conversion ratio of 128.6%. The cash flow was supported by a positive contribution from property disposals of DKK 3,189 million, while working capital remained elevated due to higher freight rates and fuel prices.
• The cash flow contributed to deleveraging, bringing the gearing ratio down to 2.5x. A share buyback programme of DKK 1,500 million has been issued today, marking the first share buyback programme since the acquisition of Schenker.
• Based on the performance in the first nine months of the year and outlook for the remainder of the year, we narrow the full-year 2026 guidance for EBIT before special items to DKK 24.0-25.0 billion (previously DKK 23.5-25.5 billion).

Jens H. Lund, Group CEO: “We delivered earnings growth in a volatile market, driven by strong results in Air & Sea and Contract Logistics. Road was affected by integration-related operational issues, but service levels recovered by quarter-end, allowing us to shift our focus to productivity, commercial initiatives and organic growth. We remain focused on completing the Schenker integration, realising synergies and advancing our 2030 ambitions through investments in AI, technology and network optimisation.”

Selected key figures and ratios for the period 1 January – 30 September 2026

	Q3 2026	Q3 2025	YTD 2026	YTD 2025
Key figures (DKKm)
Revenue	80,702	71,983	227,806	175,646
Gross profit	20,253	19,508	59,433	47,740
Operating profit (EBIT) before special items	6,606	5,434	17,716	14,019
Special items, costs	1,276	1,154	4,197	1,971
Profit for the period	3,017	2,160	7,282	7,328
Adjusted earnings for the period	4,065	3,064	10,343	8,996
Adjusted free cash flow	6,439	3,829	8,742	10,976
Ratios
Conversion ratio	32.6%	27.9%	29.8%	29.4%
Adjusted cash conversion ratio	128.6%	95.6%	79.7%	115.5%
Diluted adjusted earnings per share of DKK 1 for the last 12 months			56.1	50.3

Performance in Q3 2026
While market conditions were generally favourable in the third quarter, the demand outlook continued to be impacted by macroeconomic uncertainty from rising energy prices and global inflation. Leveraging our global network, we remained well-positioned to help our customers navigate these challenges and maintain resilient supply chains. In Q3 2026, DSV reported gross profit of DKK 20,253 million, an increase of 2.3% compared to the same period last year, while EBIT before special items increased by 19.5% to DKK 6,606 million, of which DKK 300 million were gains from property disposals. This growth was driven by the Air & Sea and Contract Logistics divisions, including cost synergies from the Schenker integration, while the Road division reported negative growth related to operational issues.

Air & Sea achieved an EBIT before special items of DKK 4,278 million, representing an increase of 18.9% compared to the same period last year. The earnings growth was mainly driven by cost synergies from the Schenker integration, lifting the conversion ratio to 45.8%, compared to 38.6% in the same period last year, while gross profit was on level with the same period last year.

Road reported an EBIT before special items of DKK 526 million, of which DKK 195 million were gains from property disposals, representing a decrease of 35.1% compared to the same period last year. The decrease was driven by negative volume growth and lower productivity following a period with reduced service reliability related to the Schenker integration. While the financial performance remained weak, the operational performance normalised at the end of Q3 2026. Focus has now shifted to improving productivity and commercial performance.

Contract Logistics generated an EBIT before special items of DKK 1,673 million, of which DKK 105 million were gains from property disposals, representing growth of 50.3% compared to the same period last year. ROIC before tax improved from 6.9% to 10.9%. The continued strong earnings growth was related to synergies from the Schenker integration, improved productivity and capacity utilisation, including the consolidation of less profitable sites.

Outlook for 2026
Based on our performance in the first nine months of 2026 and our expectations for the remainder of the year, we are narrowing the full-year outlook for 2026 as follows:

• EBIT before special items is expected to be in the range of DKK 24,000-25,000 million (previously DKK 23,500-25,500 million). The range includes expected gains from property disposals in Q4 2026 broadly in line with recent quarters.
• Due to delayed realisation of certain synergies, special items related to integration costs are now expected to be around DKK 5,500 million in 2026 (previously DKK 6,500 million), with the remaining amount expected in 2027.
• The effective tax rate is expected to remain at an elevated level around 28.0% in 2026, due to the ongoing integration of Schenker.

The main uncertainties that may affect our outlook relate to ongoing geopolitical tensions in the Middle East and trade tariffs and their potential impact on the global demand. We consistently monitor activity levels and will adjust capacity and our cost structure as necessary.

Synergies and integration costs related to Schenker
The Schenker integration is generally progressing as planned. As of Q3 2026, almost all countries had either completed integration or were in the process of integrating. The few remaining countries are expected to commence integration in Q4 2026. Annual synergies are still expected at the level of DKK 9 billion, partly offset by inflationary pressure and costs related to increased activity in Contract Logistics. The remaining synergies related to Road and certain Group functions are expected to be delayed into 2027 due to the issues in Road. Total transaction and integration costs are still expected to be around DKK 11 billion and will be recognised as special items in the statement of profit and loss. For Q3 2026, special items came to DKK 1,276 million, bringing accumulated special items to approximately DKK 8.7 billion. As certain synergies have been delayed into 2027, some of the related special items are now expected to be recognised in 2027.

Launch of share buyback programme
A separate company announcement about a new share buyback programme of DKK 1,500 million has been issued. The programme starts 21 October 2026 and will run until 1 February 2027.

Contacts
Investor Relations
Stig Frederiksen, tel. +45 43 20 36 38, stig.frederiksen@dsv.com
Alexander Plenborg, tel. +45 43 20 33 73, alexander.plenborg@dsv.com

Media
Stephan Ghisler-Solvang, tel. +45 61 22 93 92, stephan.ghisler-solvang@dsv.com
Jonatan Rying Larsen, tel. +45 25 41 77 37, press@dsv.com

Yours sincerely,
DSV A/S        

Attachment

• 1175 – Announcement (21.10.2026) – INTERIM FINANCIAL REPORT Q3 2026

Press Release

Another quarter of improvement in organic revenue trajectory

Strong liquidity underpinned by positive operating cash generation

On track to achieve full-year targets

• Recovery trajectory confirmed with continued sequential improvement in organic growth
  • Q3 2026 revenue of €1,642 million, representing a -2.4% organic decline for Atos and Eviden SBUs year-on-year, and sequentially improving, after -11.0% in Q1 2026 and -5.8% in Q2 2026
  • UK & Ireland, International Markets and France were the main contributors to the sequential improvement in organic growth
• Commercial activity reflecting usual summer seasonality
  • Order entry reached €1,024 million in Q3 2026, mostly driven by upselling activities
  • Book-to-bill (BtB) stood at c. 62%, down c. 7 pts year-on-year due to the during the summer quarter
  • Qualified pipeline slightly increased in Q3 2026, with Cybersecurity services, Data & AI and Cloud & Modern Infrastructure showing strong momentum

• Genesis continues to outperform its initial objectives, with savings targets overachieved and extended, and increasing focus on growth while simplification remains the cornerstone of all initiatives
• Key milestone reached: operations turn cash positive in Q3 for the first time since Genesis launch
  • €44 million net change in cash¹ including the significant restructuring cash impact of c. -€50 million
  • Liquidity improved to €966 million at the end of September 2026, with limited contribution of the recurring receivables factoring program at €21 million. Acceleration is expected from Q4 onward as the program continues to deploy
  • Due to slow ramp-up of the factoring program (from €8 million to €21 million), no debt was bought back on the open market during the third quarter. The Group purchased €7 million in bonds early in the fourth quarter before the closed period started.

• Acceleration in the Group’s strategic technology pillars (cybersecurity, agentic AI, digital sovereignty)
  • Launch of Atos Genesis Intelligence, our state-of-the-art end-to-end sovereign AI Suite
  • Delivery of measurable value for clients through agentic AI: Atos is deploying solutions at the heart of client operations in Europe (e.g., SPIE, UGAP and Flender), and in its own operations as Client Zero
  • AI agents available throughout the entire cyber defense lifecycle

• FY 2026 targets² confirmed
  • Organic revenue growth of around -5% (Atos & Eviden SBUs)
  • Operating margin at c. 7%
  • Positive net change in cash¹

Paris, Wednesday October 21, 2026 – Atos Group, a global leader of AI-powered digital transformation, today announces its Q3 2026 performance.

Philippe Salle, Atos Group chairman of the board of directors and chief executive officer, stated:

“The third quarter marks another important milestone in Atos Group’s recovery journey. We delivered a third consecutive quarter of sequential improvement in our organic revenue trajectory, generated cash from operations for the first time since the launch of Genesis and we continued to execute our transformation ahead of plan. These achievements are the direct results of the discipline, commitment and resilience demonstrated by our teams over the past months. While our turnaround is not complete, the foundations of a stronger and more competitive Atos Group are now firmly in place.

Our ambition now goes beyond recovery. We are focused on accelerating sustainable and profitable growth, helping our clients navigate AI-driven transformation while strengthening their digital sovereignty and cybersecurity. Our strategic offerings are gaining traction and the actions we have taken to improve portfolio quality and operational discipline are delivering tangible benefits. We remain fully focused on execution and on translating these improvements into sustainable growth and value creation.

With a strengthened balance sheet, a clearer strategic focus and encouraging commercial signals, we are confident in our ability to achieve our 2026 objectives.”

Operational performance

Group reported revenue reached €1,642 million in Q3 2026, down €50 million year-on-year at constant scope and constant perimeter.

Combined revenue for Atos and Eviden Strategic Business Units – SBU – were down -2.4% organically³ compared to the third quarter of 2025.

The Atos SBU generated reported revenue of €1,566 million, down -2.0% organically compared to Q3 2025 at current perimeter³.

The Eviden SBU reported revenue was €76 million in Q3 2026, down -10.9% organically³ compared to Q3 2025. The prior-year comparison was significantly distorted by Bull’s deconsolidation and revenue recognition timing effects, resulting in an irrelevant comparison base. Excluding that impact Eviden SBU revenues were up +5.1% organically year-on-year.

Disclosure in this section reflects the revised reporting structure of Atos Group, following the implementation of the new organization in the first half of 2025 reporting period. Atos has identified Atos France, Atos BNN (Belux, Netherlands, Nordics), Atos UK & Ireland, Atos North America, Atos GACE (Germany, Austria & Central Europe), Atos IM (International Markets), Atos Global Delivery Centers, Eviden and Global Structures as the operating segments, mirroring the internal reporting structure. This reflects the review, management and assessment of the Group’s operating results by Group Management following the implementation of the new organization.

In € million	Q3 2026 reported revenue	Q3 2025 revenue at current perimeter3*	Organic variation at current perimeter3	Q3 YTD 2026 revenue at current perimeter3*	Q3 YTD 2025 revenue at current perimeter3*	Organic variation at current perimeter3
Atos	1,566	1,598	-2.0%	4,708	5,053	-6.8%
Germany, Austria & Central Europe	333	354	-6.1%	1,011	1,115	-9.3%
North America	246	305	-19.3%	739	950	-22.2%
France	257	264	-2.7%	804	855	-6.0%
UK & Ireland	323	247	+30.8%	929	812	+14.3%
International Markets	233	224	+4.0%	679	715	-5.0%
BNN (Belux, Netherlands, Nordics)	172	201	-14.2%	541	600	-9.7%
Global Delivery Centers	2	2	-27.2%	5	6	-23.0%
Eviden	76	85	-10.9%	231	231	-0.2%
Sub-total: Atos & Eviden SBU	1,642	1,683	-2.4%	4,939	5,285	-6.5%
Global Structures	0	9	ns	7	33	ns
Group total	1,642	1,692	-3.0%	4,946	5,318	-7.0%

*: at constant scope and September 2026 average exchange rates

Atos – Germany, Austria & Central Europe revenue was €333 million in Q3 2026, representing a -6.1% organic decline compared to Q3 2025. This performance was mainly driven by a few large client ramp-downs following insourcing strategies and representing a c. 3-point impact on organic growth in the quarter. It also stemmed from the managed exit of low-profitability contracts. That was partially offset by successful fertilization and cross-selling to existing clients, as well as renewed relations with former clients.

Atos – North America revenue totaled €246 million in Q3 2026, demonstrating the stabilization of the quarterly revenues since the start of the year. Year-on-year, this represented an organic decline of -19.3%, mostly driven by low profitability contract exits and a scope reduction at existing clients. The business is expected to benefit from the visibly improving commercial momentum, with significantly growing qualified pipeline year-on-year, including related to new clients.

Atos – France revenue reached €257 million in Q3 2026. This represents a new positive inflexion in the growth curve (-2.7% organically from Q3 2025 at current perimeter) with public sector remaining soft whereas other sectors have started to recover.

Atos – UK & Ireland revenue reached €323 million in Q3 2026, up +30.8% organically year-on-year and c. +8% quarter-on-quarter, representing the 4^th consecutive quarter of growth for the region. This high and unrepeatable level of growth was due to low comps in the same period last year and to continued strong momentum in 2026, boosted by new wins in the region (in both public and commercial sectors).

Atos – International Markets revenue was €233 million in Q3 2026, up +4.0% organically year-on-year and for the first time in positive territory since the launch of Genesis. The performance was broad-based, with most regions growing and Switzerland, Middle East & Turkey, and Southeast Europe delivering double-digit growth. APAC was impacted by the expected ramp-down of a large contract following the customer’s strategic insourcing of part of its IT operations.

Atos – BNN (Belux, Netherlands & Nordics) revenue stood at €172 million in Q3 2026, down -14.2% organically compared to Q3 2025 at current perimeter. The year-on-year decline was primarily driven by managed exits from low profitability contracts and ramp-downs on existing clients, with churn partially offset by growing activity at existing clients.

Eviden revenue was €76 million in Q3 2026. The prior-year comparison was significantly distorted by Bull’s deconsolidation and revenue recognition timing effects, resulting in an irrelevant comparison base. Excluding that impact, revenues were up +5.1% organically year-on-year, confirming continued positive momentum. This underlying performance was mainly driven by growth in defense activities, particularly in mission-critical systems and cyber products, the latter growing year-on-year for the first time since the launch of Genesis. This was partly offset by the continued softness in the Middle East, impacting the Vision AI activity.

Commercial activity

Since 2025, the Group has carried out a comprehensive reset of its commercial organization to improve efficiency, increase accountability and strengthen go-to-market performance. First benefits were already visible, particularly in productivity and pipeline quality.

Order entry reached €1,024 million in Q3 2026, with France, UK&I and International Markets growing year-on-year. Key contracts signed⁴ during the quarter include:

• Exclusive partnership with EDF, France’s leading energy company, for operational information system management for nuclear power plants sold out of France, mainly in Digital Applications, as well as Atos Amplify, Data & AI, Cloud & Modern Infrastructure, Digital Workplace & Cybersecurity, signed for 15 years
• Contract with the Metropolitan Police Service in London, covering application management services across Digital Applications and Cybersecurity, for up to £350 million over six years
• Framework agreement with HM Revenue & Customs (HMRC) in United-Kingdom & Ireland, covering low-code platform leadership services in Digital Applications, for up to £78 million over three years, with two optional one-year extensions
• Contract with European Space Operator, covering Eviden SkyMon NG advanced satellite monitoring within mission-critical systems, for up to €2 million over multiple years
• Contract with Barcelona City Council, covering AI-powered digital employee support in Digital Applications, for three years, with two optional one-year extensions
• Contract with Oriola Corporation, in Belux, Netherlands & Nordics covering SAP modernization and data analytics through Smart Platforms, for €15 million over multiple years

The Group book-to-bill ratio stood at 62% in Q3 2026, down c. 7 points vs Q3 2025.

• Atos SBU Q3 2026 book-to-bill was 63%, down c. 7 pts compared to the same period last year.
• Eviden SBU book-to-bill was 59% in Q3 2026, down 18 pts from the same period last year, mainly reflecting a stronger summer timing effect on contract signings than in the prior-year period.

The renewal rate reached 93% year-to-date, compared to 91% during the same period last year.

The full backlog at the end of September 2026 was €8.4 billion, representing 1.3 years of revenue. The qualified pipeline increased modestly in the quarter after c. €1,660 million increase in H1 2026.

Update on the Genesis transformation plan execution

Since the launch in 2025, Genesis execution progressed faster than initially planned, with the three-year Genesis target savings completed. The Group extended Genesis to generate further efficiencies, while continuing to deliver tangible progress across its core pillars, including the following:

• Growth and offering portfolio management, as key priorities of Genesis’ pillars going forward:
  • Accelerated initiatives to support the three strategic technology growth pillars presented at FY 2025 (agentic AI, sovereign and cyber)
  • Continued portfolio enablement supported by the new commercial Target Operating Model, with approximately 40% of planned sessions delivered across geographies, strengthening go-to-market execution across the Group
  • Strategic partner engagement further strengthened, with a satisfaction score of 8.1/10, reflecting strong confidence in future joint growth opportunities
• Simplification, as a core driver of Genesis execution:
  • Further progress in restructuring plan execution, with approximately €50 million associated cash out during the quarter
  • Billability rate reached approximately 84% at the end of the quarter

• Continued M&A simplification in Central and Eastern Europe
• Trim and simplification of bid process to streamline administrative processes

Human resources

The Group’s total headcount stood at 53,071 at the end of September 2026, representing a decrease of -2.6% compared with the beginning of July 2026, primarily driven by the continued implementation of the Genesis headcount reduction program.

During the third quarter of 2026, the Group hired 1,336 employees, (of which 90% were direct employees), while the voluntary attrition rate stood at 10.4%, vs. 14.7% in third quarter 2025.

Q3 2026 liquidity position

As a reminder, the publication of the quarterly liquidity position is part of the regular reporting requirements defined in the December 2024 credit documentation.

The Group reached a key milestone in the quarter with first time positive cash generation since the launch of the Genesis transformation plan. Net change in cash⁵ is estimated at c. +€44 million for the period, including cash restructuring costs of c. -€50 million.

This is before the estimated impacts of:

• exchange rate fluctuation for -€6 million
• M&A for -€5 million
• change in unsolicited payments received in advance of the invoice payment due date during the quarter for -€10 million
• cash movements relating to other financial assets and liabilities for -€9 million
• factoring of trade receivables for €14 million
• net fees associated with the successful refinancing of the 1L tranche of the December 2024 debt for -€9 million.

The trade receivables factoring program is expected to continue to ramp up in the fourth quarter. It provides a secure and recurring source of funding at an all-in attractive cost of 4.25%+EURIBOR 3 months. It is committed for a duration of three years on a non-recourse basis.

As of September 30, 2026, Atos Group liquidity is estimated at 966 million. This compares with €948 million as of June 30, 2026, after repayment of €857 million for 1L on July 6, 2026, and remains well above the minimum €650 million level required by the December 2024 credit documentation. It was comprised of:

In € million	September 30, 2026 (estimated)	June 30, 2026 (actuals) after repayment of €857m of 1L debt on July 6, 2026	Variation
Cash and cash equivalents	896	878	+18
Of which payments received in advance of invoice payment due date	112	122	-10
Of which factoring of trade receivables	21	8	+14
Undrawn revolving credit facility	70	706	0
Total liquidity7	966	948	+18

Outlook

The Group confirms its fiscal year 2026 targets⁸:

• Organic revenue growth of around -5% (Atos and Eviden SBUs)
• Operating margin at c. 7%
• Positive net change in cash⁹

The Group foresees an acceleration of profitable growth and cash generation in 2027 and in 2028 and has ambitions to:

• Generate organic revenue CAGR of 5 to 7% between 2026 and 2028. Strategic, targeted and disciplined M&A could further increase revenue over the period
• Reach an operating margin of around 10% in FY 2028, supported by cost reduction measures and profitable growth, partially offset by an acceleration of R&D investments
• Achieve a leverage ratio below 1.5x net debt/OMDAL¹⁰ in fiscal year 2028. On the path to an investment grade rating, the Group expects to achieve a BB profile in 2027.

Conference call

Atos Group’s management invites you to attend the performance of the third quarter 2026 conference call on Wednesday, October 21, 2026, at 08:30 am (CEST – Paris).

You can join the webcast of the conference via the following link:

https://edge.media-server.com/mmc/p/9fe27wna

If you want to join the conference by telephone, please register via this link:

https://register-conf.media-server.com/register/BIdbcf26fcf6bc458b8d52585affe6eedf

Upon registration, you will receive the dial-in info and a unique PIN to join the call as well as an email confirmation with the details.

After the conference, a replay of the webcast will be available on Atos Group, in the investors section.

Forthcoming events

February 26, 2027 (before market opening) April 21, 2027 (before market opening) May 05, 2027 July 29, 2027 (before market opening) October 21, 2027 (before market opening)

Full year 2026 results First quarter 2027 performance General assembly Half-year 2027 results Third quarter 2027 performance

APPENDIX

Q3 2025 revenue at constant scope and exchange rates reconciliation

For the analysis of the Group’s performance, Q3 2026 revenue is compared with Q3 2025 revenue at constant scope and foreign exchange rates.

Reconciliation between the Q3 2025 reported revenue, the Q3 2025 revenue at constant scope and foreign exchange rates is presented below, by Strategic Business Unit (SBU) and by geography for the Atos SBU.

Revenue In € million	Q3 2025 published	Restate-ment	Q3 2025 restated	Internal transfers	Scope effects	Exchange rates effect	Q3 2025*
Atos	1,621	-3	1,619	0	-35	15	1,598
Germany, Austria & Central Europe	359	0	359	-1	-4	0	354
North America	299	-3	296	1	0	7	305
France	264	0	264	0	0	0	264
UK & Ireland	243	0	243	0	0	4	247
International Markets	251	0	251	0	-31	4	224
BNN (Benelux, Netherlands, Nordics)	202	0	202	0	-1	0	201
GDC	2	0	2	0	0	0	2
Eviden	356	0	356	0	-272	1	85
Sub-total: Atos & Eviden SBUs	1,977	-3	1,975	0	-308	16	1,683
Global Structures	0	0	0	0	9	0	9
Group Total	1,977	-3	1,975	0	-299	16	1,692

*: at constant scope in September 2026 average exchange rates

Restatement reflects a change in revenue recognition methodology.

Scope effects amounted to €-299 million, mainly related to the disposal of Advanced Computing activities, Ideal GRP, activities in South America.

Currency effects positively impacted revenue by €16 million. They mostly came from the appreciation of the US dollar, the British pound and the Chinese yuan.

Q3 YTD 2025 revenue at constant scope and exchange rate reconciliation

For the analysis of the Group’s performance, revenue for Q3 YTD 2026 is compared with Q3 YTD 2025 revenue at constant scope and foreign exchange rates.

Reconciliation between the Q3 YTD 2025 reported revenue, and the Q3 YTD 2025 revenue at
constant scope and foreign exchange rates is presented below, by segment.

Revenue In € million	Q3 YTD 2025 published	Restate-ment	Q3 YTD 2025 restated	Internal transfers	Scope effects	Exchange rates effect	Q3 YTD 2025*
Atos	5,224	-9	5,216	0	-103	-59	5,053
Germany, Austria & Central Europe	1,126	0	1,126	-4	-8	1	1,115
North America	993	-9	985	4	-1	-38	950
France	855	0	855	0	0	0	855
UK & Ireland	825	0	825	0	0	-13	812
International Markets	813	0	813	0	-90	-9	715
BNN(Benelux, Netherlands, Nordics)	604	0	604	0	-4	0	600
GDC	7	0	7	0	0	-1	6
Eviden	773	0	773	0	-537	-5	231
Sub-total: Atos & Eviden SBUs	5,998	-9	5,989	0	-640	-64	5,285
Global Structures	0	0	0	0	33	0	33
Group Total	5,998	-9	5,989	0	-608	-64	5,318

*: at constant scope and September 2026 average exchange rates

Glossary

Operational capital employed: Operational capital employed comprises net fixed assets and net working capital but excludes goodwill and net assets held for sale.

Current and non-current assets or liabilities: A current and non-current distinction is made between assets and liabilities on the consolidated statement of financial position. Atos has classified as current assets and liabilities those assets and liabilities that Atos expects to realize, use or settle during its normal cycle of operations, which can extend beyond 12 months following the period end. Current assets and liabilities, excluding the current portion of borrowings, lease liabilities and provisions, and current financial instruments represent the Group’s working capital requirement.

DSO: (Days of Sales Outstanding). DSO is the amount of trade accounts receivable (including contract assets and liabilities) expressed in days of revenue (on a last-in, first-out basis). The number of days is calculated in accordance with the Gregorian calendar.

Organic growth: Organic growth represents the percent growth of a unit based on a constant scope and exchange rates basis.

CAGR: The Compound Annual Growth Rate reflects the mean annual growth rate over a specified period of time longer than one year. It is calculated by dividing the value at the end of the period in question by its value at the beginning of that period, raising the result to the power of one divided by the period length, and subtracting one from the subsequent result. As an example:

2019-2021 revenue CAGR = (Revenue 2021 / Revenue 2018) (1/3) -1

Operating margin: Operating margin equals External Revenues less personnel and operating expenses. It is calculated before Other operating income and expenses as defined below.

Other operating income and expense: 

Other operating income and expenses include:

• The amortization and impairment of intangible assets recognized as part of business combinations, such as customer relationships, technologies and goodwill
• When accounting for business combinations, the Group may record provisions in the opening statement of financial position for a period of 12 months beyond the business combination date. After the 12-month period, unused provisions arising from changes in circumstances are released through the income statement under “other operating income and expenses”
• The cost of acquiring and integrating newly controlled entities, including earn out with or without presence conditions
• The net gains or losses on disposals of consolidated companies or businesses
• The fair value of shares granted to employees including social contributions
• The restructuring and rationalization expense relating to business combinations or qualified as unusual, infrequent and abnormal. When a restructuring plan qualifies for Other operating income and expense, the related real estate rationalization & associated costs regarding premises are presented on the same line
• The curtailment effects on restructuring costs and the effects of plan amendments on defined benefit plans resulting from triggering events that are not under control of Atos management
• The net gain or loss on tangible and intangible assets that are not part of Atos core business such as real estate
• Other unusual, abnormal and infrequent income or expenses such as major disputes or litigation

Gross margin and indirect costs: Gross margin is composed of revenue less the direct costs of goods sold. Direct costs relate to the generation of products and/or services delivered to customers, while indirect costs include all costs related to indirect staff (defined hereafter), which are not directly linked to the realization of the revenue. The operating margin comprises gross margin less indirect costs.

EBITDA (Earnings Before Interest, Tax, Depreciation and Amortization): For Atos, EBITDA is based on Operating Margin less non-cash items and is referred to as OMDA (Operating Margin before Depreciation and Amortization).

OMDA (Operating Margin before Depreciation and Amortization) is calculated as follows:

Operating margin, plus:

• Depreciation of fixed assets (as disclosed in the “financial report”)
• Depreciation of right of use (as disclosed in the “financial report”)
• Net book value of assets sold/written of (as disclosed in the “financial report”)
• Net charge (release) of provisions (composed of net charge of provisions for current assets and net charge of provisions for contingencies and losses, both disclosed in the “financial report”)
• Net charge (release) of provisions for pensions (as disclosed in the “financial report”)

OMDAL: OMDA – lease repayments.

Gearing: The proportion, expressed as a percentage of net debt to total shareholders’ equity (Group share and minority interests).

Interest cover ratio: Operating margin divided by the net cost of financial debt, expressed as a multiple.

Leverage ratio: Net debt (before IFRS 9 fair value adjustment) / OMDAL last 12 months

Operating income (loss): Operating income (loss) comprises net income (loss) before deferred and current income taxes, net financial income (expense), and share of net profit (loss) of equity-accounted investments.

Cash flow from operations: Cash flow coming from the operations and calculated as a difference between OMDA, net capital expenditures, lease payment and change in working capital requirement.

Net cash or net debt: Net cash or net debt comprises total borrowings (bonds, short-term and long-term loans, securitization and other borrowings), short-term financial assets and liabilities bearing interest with maturity of less than 12 months, less cash and cash equivalents. Liabilities associated with lease contracts and derivatives are excluded from the net debt.

Net change in cash: net change in cash is obtained by deducting from Free Cash Flow the impact of non-structural working capital optimization actions, such as unsolicited customer payments received before the invoice due date. Net change in cash excludes:

• net financial debt repayments;
• net cash inflows (outflows) from acquisitions or disposals of businesses or entities;
• capital increases, share buybacks, dividends paid to shareholders and non-controlling interests;
• cash movements relating to other financial assets and liabilities, such as deposits on escrow accounts used as cash collateral;
• foreign exchange impacts on cash.

Free Cash Flow (FCF): The Free Cash Flow represents the change in net cash or net debt, excluding capital increase, share buyback, dividends paid to shareholders and non-controlling interests, net acquisition or disposal of companies.

Earnings (loss) per share (EPS): Basic EPS is the net income (loss) divided by the weighted-average number of common shares outstanding during the period. Diluted EPS is the net income (loss) divided by the diluted weighted-average number of common shares for the period (number of shares outstanding plus dilutive instruments with dilutive effect).

Revenue: Revenue related to Atos’s sales to third parties (excluding VAT).

TCV (Total Contract Value): The Total Value of a Contract at signature (provision or estimation) over its duration represents the firm order and contractual part of the contract excluding any clause on the decision of the client, as anticipated withdrawal clause, additional option or renewal.
Order entry/bookings: The TCV, orders or amendments signed during a defined period. When an offer is won (contract signed), the total contract value is added to the backlog and the order entry is recognized.

Book-to-bill: The book-to-bill is the ratio expressed as a percentage of the order entry in a period divided by the revenue of the same period.

Backlog/Order cover: The value of signed contracts, orders and amendments that remain to be recognized over their contract lives. It may include revenue recognized on contracts based on the actual use of billable services, such as volume-based considerations. It therefore does not represent the transaction price allocated to performance obligations not yet satisfied (backlog) as defined by IFRS 15.

Pipeline: The value of revenues that may be earned from outstanding commercial proposals issued to clients. A qualified pipeline applies an estimated percentage likelihood of proposal success.

Direct Staff: Direct staff include permanent staff and subcontractors, whose work is billable to a third party.

Indirect staff: Indirect staff include permanent staff or subcontractors, who are not billable to clients. Indirect staff are not directly involved in the generation of products and/or services delivered to clients.

Disclaimer

This document contains forward-looking statements that involve risks and uncertainties, including references, concerning the Group’s expected growth and profitability in the future which may significantly impact the expected performance indicated in the forward-looking statements. These risks and uncertainties are linked to factors out of the control of the Company and not precisely estimated, such as market conditions or competitors’ behaviors. Any forward-looking statements made in this document are statements about Atos Group’s beliefs and expectations and should be evaluated as such. Forward-looking statements include statements that may relate to Atos Group’s plans, objectives, strategies, goals, future events, future revenues or synergies, or performance, and other information that is not historical information. Actual events or results may differ from those described in this document due to a number of risks and uncertainties that are described within the 2025 Universal Registration Document filed with the Autorité des Marchés Financiers (AMF) on March 10, 2026 under the registration number D.26-0075. Atos Group does not undertake, and specifically disclaims, any obligation or responsibility to update or amend any of the information above except as otherwise required by law.

This document does not contain or constitute an offer of Atos Group’s shares for sale or an invitation or inducement to invest in Atos Group’s shares in France, the United States of America or any other jurisdiction. This document includes information on specific transactions that shall be considered as projects only. In particular, any decision relating to the information or projects mentioned in this document and their terms and conditions will only be made after the ongoing in-depth analysis considering tax, legal, operational, finance, HR and all other relevant aspects have been completed and will be subject to general market conditions and other customary conditions, including governance bodies and shareholders’ approval as well as appropriate processes with the relevant employee representative bodies in accordance with applicable laws.

About Atos Group

Atos Group is a global leader in digital transformation with c. 53,000 employees and annual revenue of c. €7.2 billion, operating in 54 countries under two brands – Atos for services and Eviden for products and systems. European number one in cybersecurity and a leader in cloud, Atos Group is committed to a secure and decarbonized future and provides tailored AI-powered, end-to-end solutions for all industries. Atos Group is listed on Euronext Paris. 

Contacts

Investor Relations: investors@atosgroup.com

Individual shareholders: +33 8 05 65 00 75

Media Relations: globalprteam@atosgroup.com

        

---

¹ Net change in cash is obtained by deducting from Free Cash Flow the impact of non-structural working capital optimization actions, such as unsolicited customer payments received before the invoice due date. It excludes i/ net financial debt repayments; ii/ net cash inflows (outflows) from acquisitions or disposals of businesses or entities; iii/ capital increases, share buybacks and dividends paid to shareholders and non-controlling interests; iv/ cash movements relating to other financial assets and liabilities, such as deposits on escrow accounts used as cash collateral; and v/ foreign exchange impacts on cash

² Current perimeter corresponds to Group’s baseline for establishing future ambition: for all years, excluding the estimated impact of Advanced Computing activities, South America operations and Ideal GRP divestitures.

³ Current perimeter corresponds to Group’s baseline for establishing future ambition: for all years, excluding the
estimated impact of Advanced Computing activities, South America operations and Ideal GRP divestitures.
⁴ The amounts indicated represent a maximum cap over the term of the agreement, rather than a firm guaranteed amount.

⁵ Net change in cash is obtained by deducting from Free Cash Flow the impact of non-structural working capital optimization actions, such as unsolicited customer payments received before the invoice due date. It excludes i/ net financial debt repayments; ii/ net cash inflows (outflows) from acquisitions or disposals of businesses or entities; iii/ capital increases, share buybacks and dividends paid to shareholders and non-controlling interests; iv/ cash movements relating to other financial assets and liabilities, such as deposits on escrow accounts used as cash collateral; and v/ foreign exchange impacts on cash.

⁶ New RCF of €110 million includes available cash for €70 million and bank guarantee for €40 million.

⁷ Liquidity is defined as the sum of (i) the consolidated cash and cash-equivalent position of the Group and (ii) the amounts available under any undrawn committed facilities (including committed overdrafts). Consolidated cash and cash-equivalent includes trapped cash and unpooled cash and excludes cash held in escrow accounts in order to provide cash collateral.

⁸ Current perimeter corresponds to Group’s baseline for establishing future ambition: for all years, excluding the estimated impact of Advanced Computing activities, South America operations and Ideal GRP divestitures.

⁹ Net change in cash is obtained by deducting from Free Cash Flow the impact of non-structural working capital optimization actions, such as unsolicited customer payments received before the invoice due date. It excludes i/ net financial debt repayments; ii/ net cash inflows (outflows) from acquisitions or disposals of businesses or entities; iii/ capital increases, share buybacks and dividends paid to shareholders and non-controlling interests; iv/ cash movements relating to other financial assets and liabilities, such as deposits on escrow accounts used as cash collateral; and v/ foreign exchange impacts on cash.

¹⁰ Defined as Operating Margin before Depreciation, Amortization and Leases.

Attachment

• PR – Atos Group – Q3’26 Performance

Company Announcement No. 1174

This announcement contains publication of inside information pursuant to Article 17 of the EU Market Abuse Regulation.

With the integration of Schenker expected to be completed by the end of 2026 and with DSV on track for further deleveraging of its capital structure, the Board of Directors of DSV A/S has decided to exercise the authority to buy back shares granted by the Annual General Meeting on 20 March 2025. The authority is valid until 20 March 2030 and covers a maximum of 24,044,000 shares.

Purpose

The purpose of the share buyback is to adjust the capital structure and meet obligations relating to the Group’s share-based incentive programmes. Any shares not used for these programmes will be proposed for cancellation at a future General Meeting of DSV A/S.

Time frame

The share buyback programme will commence on 21 October 2026 and will be completed by 1 February 2027, at the latest, both days inclusive. During this period, DSV A/S will buy own shares up to a maximum of DKK 1,500 million in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules.

Buyback terms 

•  DSV A/S is required to retain a lead manager who is to make its own trading decisions independently of and without influence from DSV A/S and execute the buyback within the announced limits. DSV A/S has designated Danske Bank A/S as its lead manager for the share buyback.
•  Under the share buyback programme, DSV A/S may repurchase shares up to a maximum aggregate purchase price of DKK 1,500 million, and no more than 2,600,000 shares, corresponding to 1.09% of the current share capital of DSV A/S.
•  The shares may in no event be bought at a price deviating by more than 5 per cent from the most recently quoted market price of the shares at the time of purchase.
•  The shares shall not be purchased at a price higher than the price of the last independent trade or higher than the current highest independent bid on the trading venue on which the purchase is carried out.
•  The maximum number of shares that can be repurchased on any single trading day may not be greater than 25% of the average daily trading volume of DSV shares on Nasdaq Copenhagen during the 20 preceding trading days before the trading day.

A company announcement of any transactions under the programme will be published every week after commencement and at the end of the programme.

Contacts
Investor Relations
Stig Frederiksen, tel. +45 29 34 98 70, stig.frederiksen@dsv.com
Alexander Plenborg, tel. +45 43 20 33 73, alexander.plenborg@dsv.com

Yours sincerely,
DSV A/S

Attachment

• 1174 – Announcement (21.10.2026) – LAUNCH OF NEW SHARE BUYBACK PROGRAMME ACCORDING TO THE SAFE HARBOUR METHOD

Nasdaq Copenhagen
Euronext Dublin
London Stock Exchange
Other stakeholders

21 October 2026

Ringkjøbing Landbobank’s interim report for the first three quarters of 2026

The bank’s board of directors and general management today approved the interim report for the first three quarters of 2026

The bank delivers core earnings of DKK 2,434 million and net profit of DKK 1,811 million for the first three quarters of the year. The net profit is equivalent to a 23% p.a. return on tangible equity (ROTE).

Core earnings

(DKK million)	Q3 2026	Q3 2025	Q1-Q3 2026	Q1-Q3 2025	2025	2024	2023	2022
Total core income	1,099	983	3,219	3,073	4,089	4,068	3,828	2,862
Total expenses and depreciation	262	253	818	787	1,080	1,044	963	891
Core earnings before impairment charges for loans	837	730	2,401	2,286	3,009	3,024	2,865	1,971
Impairment charges for loans etc.	+2	+11	+33	+35	+41	+3	-1	-2
Core earnings	839	741	2,434	2,321	3,050	3,027	2,864	1,969
Result for the portfolio etc.	-12	+9	-14	+5	+26	+62	-7	-69
Amortisation and write-downs on intangible assets	5	5	15	15	20	20	20	20
Tax	205	183	594	558	743	768	682	385
Net profit	617	562	1,811	1,753	2,313	2,301	2,155	1,495

Interim report – highlights

• The net profit is DKK 617 million for the third quarter, equivalent to a 23% p.a. return on equity
• Earnings per share increase compared to 2025, by 15% for the third quarter and by 8% for the first three quarters
• Core income is DKK 1,099 million in the quarter, a 12% increase compared to 2025
• Costs in the quarter increase by 4% compared to the third quarter of 2025. The cost/income ratio is 25.4%
• DKK 2 million impairment reversal in Q3, marking 19 consecutive quarters of near-zero charges or reversals
• Very satisfactory customer growth, with credit intermediation up 12% p.a. and deposits up 14% p.a.
• New DKK 400 million share buyback programme initiated in early October
• The Ringkjøbing Landbobank brand continues to hold first place in Voxmeter’s Image Survey
• The bank’s ESG rating with MSCI was raised to AAA
• The expected net profit is revised to the upper part of the DKK 2.2-2.5 billion range

Yours sincerely

Ringkjøbing Landbobank

John Fisker
CEO

Attachments

• Interim report for Q1-Q3 2026 EN
• RILBA-2026-9-30 EN
• Summary interim report Q3 2026 EN

Third quarter

• Order intake increased by 29% to SEK 1,104 m (855). Organically, order intake increased by 22%
• Net sales increased by 15% to SEK 1,024 m (894). Organically, net sales increased by 6%
• EBITA reached SEK 280 m (242), equal to a 27.4% (27.1) margin
• EBIT reached SEK 253 m (213), equal to a 24.7% (23.9) operating margin
• Profit after tax totaled SEK 164 m (164) and basic earnings per share were SEK 3.27 (3.26)
• Profit after tax adjusted for amortization of excess values from acquisitions (adjusted profit after tax) totaled SEK 192 m (192) and adjusted basic earnings per share were SEK 3.82 (3.83)
• Cash flow from operating activities amounted to SEK 333 m (258)
• Public tender offer for ROBOT S.A.

First nine months

• Order intake increased by 23% to SEK 3,191 m (2,601). Organically, order intake increased by 15%
• Net sales increased by 14% to SEK 2,987 m (2,627). Organically, net sales increased by 11%
• EBITA reached SEK 810 m (615), equal to a 27.1% (23.4) margin
• EBIT reached SEK 728 m (526), equal to a 24.4% (20.0) operating margin
• Profit after tax totaled SEK 482 m (363) and basic earnings per share were SEK 9.60 (7.23)
• Profit after tax adjusted for amortization of excess values from acquisitions and non-recurring items (adjusted profit after tax), totaled SEK 546 m (451) and adjusted basic earnings per share were SEK 11.24 (8.98)
• Cash flow from operating activities amounted to SEK 916 m (646)
• Acquisition of Molex’s industrial communications business
• Minority investment in AI company Ekkono

CEO comments

A QUARTER WITH REVENUE EXCEEDING SEK 1 BILLION
The market continued to develop favorably during the quarter, and for the first time HMS surpassed the milestone of SEK 1 billion in quarterly revenue.

Order intake amounted to SEK 1,104 million (855), corresponding to organic growth of 22%. In addition to the general improvement in the industrial economy, where the global purchasing managers’ index reaching its highest level since 2022 during the quarter, investments in data centers and the semiconductor industry continued to support our growth. We also see that the increased cost pressure in the component market is broadening and now extends beyond memory components to include printed circuit boards and other components. Concerns over longer lead times and upcoming price increases led some customers to place order in advance. We estimate that the combined positive effect of these orders amounted to approximately SEK 70 million during the quarter, primarily within the Industrial Network Technology (INT) division.

Revenue reached SEK 1,024 million (894), representing growth of 15%, of which 6% was organic. INT and New Industries (NI) are the primary drivers of this growth. The gross margin amounted to 62.7% (64.1). Higher component prices and tariffs, which now affect a broader share of our product portfolio, had a negative impact on the gross margin. At the same time, higher volumes and favorable currency effects contributed positively.

We continue to invest in our organization, with a focus on strengthening development capabilities and building competence within AI. Operating expenses totaled SEK 391 million (362), corresponding to an organic increase of 6%. The strong revenue performance laid the foundation for a new record EBITA of SEK 280 million (242), corresponding to an EBITA margin of 27.4% (27.1).

Cash flow also remained strong, amounting to SEK 333 million (258), partly driven by temporary improvements in working capital. This contributed to reducing net debt in relation to EBITDA excluding IFRS 16 to 1.52x (2.77x), further strengthening our position for continued growth.

CONTINUED POSITIVE DEVELOPMENT IN ASIA AND RECOVERY IN EUROPE
Asia continued to perform positively, with organic order intake growth exceeding 40% during the quarter. Both China and Japan delivered solid growth. In Japan, several customers resumed ordering after several quarters of restrained purchasing activity.

In Europe, the broad-based recovery continued following weaker comparison years in 2024 and 2025, resulting in organic order growth of approximately 20%. The strategically important DACH region developed in line with this trend. The order intake also grew in North America by just under 10% during the quarter, despite strong comparables from the previous year.

HIGHER COMPONENT COSTS AND BROADER TARIFFS PUT PRESSURE ON THE GROSS MARGIN
We have previously reported rising component prices. Initially, these increases were primarily related to memory components, where prices have risen several hundred percent due to strong demand from, among other things, data centers. We now see cost increases spreading to areas such as printed circuit boards and passive components.

In addition, tariff regulations governing trade between Europe and the United States, and not least between Canada and the United States, changed during the summer. Several product categories that were previously exempt are now subject to tariffs, negatively affecting HMS.

To offset these cost increases, HMS informed customers during the quarter of price increases that will take effect on January 1, 2027. As a result, the gross margin is expected to remain under pressure during the fourth quarter and potentially into 2027 until the new pricing has had full effect.

PUBLIC TENDER OFFER WITHIN NEW INDUSTRIES
During the quarter, HMS announced a public tender offer for the Spanish company Robot S.A. Robot is a well-established provider of sensors, room controllers, and building automation systems, with a particular focus on the hospitality sector. The company’s offering of improved indoor climate and reduced energy consumption aligns well with HMS’s building automation business.

At the time of the announcement, shareholders representing more than 77% of the shares had already committed to accepting the offer. HMS expects to complete the transaction before the end of 2026. Robot is a good fit with the building automation business within the New Industries division, where the company will be integrated following the completion of the transaction.

CONTINUED PROGRESS IN INFORMATION SECURITY
During the quarter, HMS achieved global ISO/IEC 27001 certification, an important recognition of our long-term commitment to information security. The certification strengthens customer confidence in our solutions and confirms that we operate in accordance with internationally recognized cybersecurity standards. As regulatory requirements increase and customer expectations continue to rise, we view this as an important competitive advantage and a natural part of our offering.

OUTLOOK
Demand has remained solid and broad-based across our major markets so far this year. At the same time, rising component prices, new trade tensions, and geopolitical uncertainty in the Middle East contribute to a degree of uncertainty regarding future market developments. Despite these factors, many of our industrial customers continue to execute their investment plans and business activities, and we remain positive about the medium-term growth potential.

In the longer term, we believe that the trend towards a more regionalized industrial production landscape in North America, Europe, China, and Southeast Asia will drive increased demand for automation, digitalization, and industrial communication, a development that benefits HMS. Through continued investments in product development, innovation, and sales, we see good opportunities to win new customers and grow with existing ones. Creating profitable growth, both organically and through acquisitions, remains our priority.

Halmstad October 21, 2026

Staffan Dahlström
Chief Executive Officer

For more information, please contact:
Staffan Dahlström, CEO HMS, +46 (0)35 17 29 01
Joakim Nideborn, CFO HMS, +46 (0)35 710 6983

This information is such that HMS Networks AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the contact persons set out above, at 07.30 CEST on October 21, 2026.

HMS Networks AB (publ) is a market-leading provider of solutions in Industrial Information and Communication Technology (Industrial ICT) and employs over 1,100 people. Local sales and support are handled through over 20 sales offices all over the world, as well as through a wide network of distributors and partners. HMS reported sales of SEK 3,577 million in 2025 and is listed on the NASDAQ OMX in Stockholm in the Large Cap segment and Telecommunications sector.

Attachment

• HMS Networks Q3 Report 2026

PRESS RELEASE

Courbevoie, France – October 21, 2026

Double digit total revenue growth in the third quarter of 2026;

Organic revenue growth sequential improvement;

2026 outlook confirmed

The execution of LEAP | 28 has transformed Bureau Veritas into a more focused, faster-growing and higher-performing multi-specialist company. Its Product Line-centric operating model combines the Company’s global scale and resilience with clear priorities, stronger accountability and deep specialist expertise. This creates a more repeatable growth model, enabling faster execution, stronger capabilities and higher conversion of growth into profitability.

Q3 2026 Key figures¹

• New reporting structure effective July 1^st, 2026, comprising four divisions: Industrials & Commodities, Buildings & Infrastructure, Business Assurance, and Product Testing & Services, excluding the planned for exit businesses of Oil & Petrochemicals and Coal Testing and Inspection, and “Government Services”;
• Revenue of EUR 1,569.7 million, up 10.1% year-on-year and up 6.2% organically;

• Positive scope effect of 1.8%, from accelerated bolt-on acquisitions (+2.7% contribution), net of disposals (-0.9%);

• Positive currency impact of 2.1%, mainly resulting from the dollar strengthening against the euro.

Q3 2026 Highlights

• Broad growth across most divisions and geographies; with strong organic growth from Buildings & Infrastructure at +7.9% and Product Testing & Services at +7.0%, robust growth for Industrials & Commodities at +5.1%, and moderate for Business Assurance at +3.2%;
• Three years of strong organic growth and a completion of c. 21% portfolio rotation support LEAP | 28 ambitions that were confirmed at the 2026 Capital Markets Day;
• Total revenue growth target at constant currency upgraded to a double-digit CAGR for 2027-2028;
• AI identified as a key lever for both growth and performance. Commitment for EUR 1 billion revenue ambition for AI-driven markets and services by 2030;
• Successful placement of EUR 700 million, A3-rated bond due in September 2034, with a 4.125% coupon, most debt maturities now extend beyond 2031 and are at fixed interest rates;
• A third of the EUR 200 million share buyback program announced at the end of February 2026 completed.

Confirmed 2026 Outlook

In a fast-changing global business environment, the Company confirms its full year 2026 guidance. This is building on a solid 9-month delivery, a growing pipeline, and a reshaped portfolio². The full-year 2026 guidance is as follows:

• Mid-to-high single-digit organic revenue growth
• Adjusted operating margin improvement at constant exchange rates
• Strong cash flow generation

The Company is fully committed to its LEAP | 28 financial guidance, capitalizing on favorable market trends, and on the sustained execution of the strategy’s portfolio and performance programs. 

Hinda Gharbi, Chief Executive Officer, commented:

“The third quarter of 2026 marks another quarter of solid execution, with organic revenue growth of 6.2% in a volatile geopolitical and macroeconomic environment. I would like to thank all our colleagues around the world for their contributions.

This performance confirms that the rotation of our portfolio positions us on growth markets. Additionally, the recently completed acquisitions expand our capabilities, further strengthening our market leadership position. Growth at constant currency was high single-digit, and with positive currency effects, total growth reached double-digits in the quarter.

At our Capital Markets Day in September, we confirmed our LEAP | 28 ambitions and outlined how we will amplify our execution over the next two years. We will continue our disciplined M&A to deliver on our upgraded total revenue growth target to a double-digit CAGR for 2027 and 2028. In parallel, we will continue to strengthen operational leverage and functional scalability, while completing our people programs.

AI is both a growth catalyst and a transformation lever for Bureau Veritas. Our ambition is to generate EUR 1 billion in revenue from AI-driven markets and services by 2030. We remain fully committed to delivering our 2026 outlook and our LEAP | 28 financial ambitions.”

Q3 2026 KEY FIGURES

The execution of LEAP | 28 is reshaping Bureau Veritas’ portfolio, accelerating its exposure to higher-growth markets and transforming its business mix. As a result, the Company’s organization has evolved, and its reporting structure is evolving accordingly. To better reflect this transformation and to provide the market with a clearer view of the growth algorithm, Bureau Veritas is moving from six to four reporting lines, aligning external reporting with its current organization.

The reporting is now around 4 Divisions :

• Industrials & Commodities;
• Buildings & Infrastructure;
• Business Assurance;
• Product Testing & Services.

The change was effective starting from July 1^st 2026, and is reflected in Q3 2026 revenue release.

			GROWTH
IN EUR MILLION	Q3 2026	Q3 2025	CHANGE	ORGANIC	SCOPE	CURRENCY
Industrials & Commodities	591.0	543.7	+8.7%	+5.1%	+0.8%	2.8%
Buildings & Infrastructure	562.3	494.3	+13.7%	+7.9%	+4.2%	1.6%
Business Assurance	137.4	131.6	+4.4%	+3.2%	+0.1%	1.1%
Product Testing & Services	279.0	255.6	+9.2%	+7.0%	+0.2%	2.0%
Total Q3 revenue	1 569.7	1 425.2	+10.1%	+6.2%	+1.8%	2.1%

Quarterly revenue figures for year-to-date 2026 and full-year 2025 are provided in the appendix.

• Total double digit revenue growth in the third quarter

Revenue in the third quarter of 2026 amounted to EUR 1,569.7 million, a 10.1% increase compared to the third quarter of 2025. The Company delivered organic growth of 6.2%, showing a slight sequential acceleration compared to 5.9% delivered in the second quarter of the year.

By business, and on an organic basis, the growth was led by Buildings & Infrastructure, up 7.9%, and Product Testing & Services up 7.0%, Industrials & Commodities up 5.1%, while moderate growth was achieved for Business Assurance, up 3.2%, compared to the third quarter of 2025.

Geographically, the performance was solid across the board:    

• Europe (c. 34% of revenue, +2.6% organically) was supported by good momentum in the UK, Italy and France.
• Asia-Pacific (c. 30% of revenue, +8.6% organically) was driven by strong activity in China and South Asia.
• The Americas (c. 27% of revenue, +8.7% organically) delivered strong growth, supported by solid momentum in North America, notably for mission critical assets.
• Africa and the Middle East (c. 9% of revenue, +5.6% organically) demonstrated resilience in a fast-changing geopolitical environment.

The scope effect was positive at 1.8%, reflecting bolt-on acquisitions (contributing to +2.7%) finalized in the past few quarters and partially offset by the impact of divestments completed over the last twelve months (contributing to -0.9%).

Currency fluctuations had a positive impact of 2.1%, driven by the strengthening of the dollar against the euro, following two quarters of negative year-to-date currency effects.

• Solid financial position

As of September 30^th, 2026, net financial debt was broadly unchanged from June 30, 2026. The Group had more than EUR 1.0 billion in available cash and cash equivalents and EUR 600 million in undrawn committed credit lines. Following the September refinancing, most debt maturities now extend beyond 2031 and are at fixed interest rates.

In September 2026, Bureau Veritas placed a EUR 700 million A3-rated bond due in 2034 with a 4.125% coupon to refinance maturities in September 2026 and January 2027. The transaction attracted strong investor demand.

2026 SHARE BUYBACK PROGRAM

In line with the commitment to continue to improve shareholder returns, on February 25, 2026, the Company announced a new EUR 200 million share buyback program, to be completed within the next twelve months.

In accordance with the terms of the share buyback program approved by the Annual General Meeting, the purchased shares will be used for any purpose authorized by the Company’s shareholders.

As of October 19, 2026, the Company had repurchased 2.5 million shares for a total amount of EUR 68 million.

2026 CAPITAL MARKETS DAY

On September 22, 2026, Bureau Veritas hosted its Capital Markets Day and confirmed its LEAP | 28 ambitions, building on three years of strong execution.

Since the launch of the strategy, the Company has delivered sustained organic growth and margin improvement while rotating approximately 21% of its portfolio. This transformation has supported a simpler, Product Line-centric multi-specialist operating model structured around four divisions and ten Product Lines.

For 2027-2028, Bureau Veritas intends to accelerate M&A, complete the global rollout of its performance and people programs, and further leverage digital and AI. The Company confirmed its 2028 financial ambitions and upgraded its total revenue growth target to a double-digit CAGR for 2027-2028, while narrowing its leverage range to 1.5x-2.0x net debt/EBITDA.

AI will also act as a growth catalyst and transformation lever, with a target of EUR 1 billion in revenue from AI-driven markets and services by 2030.

For more information, the press releases are available by clicking here.

EXECUTIVE COMMITTEE LEADERSHIP CHANGES

Effective October 1^st 2026, Angelo Piccirillo is appointed Chief Legal Officer. He will lead the Company’s Legal function and Internal Audit, ensuring continued excellence in governance, compliance, and risk management. Angelo Piccirillo was previously Group General Counsel at Sodexo. He succeeds Béatrice Place-Faget, who left Bureau Veritas to pursue other interests.

CORPORATE SOCIAL RESPONSIBILITY COMMITMENTS

Bureau Veritas obtained SBTi validation of its enhanced Scope 3 methodology and associated 2030 emissions reduction targets. The strengthened approach improves the visibility of emissions across the value chain, reinforces the robustness of the Group’s climate reporting framework and further supports its decarbonization ambitions.

• Corporate Social Responsibility (CSR) key indicators

	UNITED NATIONS’ SDGS	Q3 2025	Q3 2026	2028 TARGET
ENVIRONMENT / NATURAL CAPITAL
CO2 emissions (Scopes 1 & 2, 1,000 tons)3	#13	128	122	107
SOCIAL & HUMAN CAPITAL
Total Accident Rate (TAR)4	#3	0.24	0.23	0.23
Gender balance in senior leadership (EC-II)5	#5	27.0%	30.7%	36.0%
Number of learning hours per employee (per year)6	#8	40.0	45.3	40.0
GOVERNANCE
Proportion of employees trained to the Code of Ethics	#16	99.4%	99.6%	99.0%

CONFIRMED 2026 OUTLOOK AND LEAP | 28 AMBITION

In a fast-changing global business environment, the Company confirms its full year 2026 guidance. This is building on a solid 9-month delivery, a growing pipeline, and a reshaped portfolio⁷. The full-year 2026 guidance is as follows:

• Mid-to-high single-digit organic revenue growth
• Adjusted operating margin improvement at constant exchange rates
• Strong cash flow generation

The Company is fully committed to its LEAP | 28 financial guidance, capitalizing on favorable market trends, and on the sustained execution of the strategy’s portfolio and performance programs.

• LEAP | 28 ambition

On September 22, 2026, Bureau Veritas hosted its Capital Markets Day. The Company presented an update on the progress of its LEAP | 28 strategy and is building on three years of consistent execution to amplify its delivery in 2027-2028:

LEAP | 28 AMBITION (2024-2028) CONFIRMED	STRONGER M&A COMPONENT (2027–2028)
Mid to high-single digit organic revenue growth High-single digit total revenue CAGR8	Confirmed Upgraded to double-digit
Consistent margin improvement8	Confirmed
Above 90%9 cash conversion 1x–2x leverage	Strong 1.5x–2x
Double digit shareholder returns, based on EPS CAGR8 + dividend yield	Confirmed

• A disciplined approach to capital allocation, driving superior returns

During the duration of its plan, Bureau Veritas will maintain a disciplined capital allocation policy, supporting accelerated M&A and active portfolio management while preserving financial flexibility. Capex and dividend policies remain unchanged, and the leverage range is tightened from 1.0x–2.0x to 1.5x–2.0x net debt/EBITDA by 2028.

ASSUMPTIONS
Capex	c.2.5%-3.0% of Company revenue
M&A	Focus on bolt on and mid-sized strategic deals
Dividend	65% payout ratio of adjusted net income
Leverage	1.5x-2.0x net debt/EBITDA
ROIC10	Above 20.0%

This disciplined capital allocation framework is expected to sustain attractive returns through the cycle. Bureau Veritas targets ROIC⁶ above 20% by 2028, supported by adjusted operating margin ramp-up, portfolio high-grading and continued financial discipline.

Q3 2026 BUSINESS REVIEW

INDUSTRIALS & COMMODITIES

IN EUR MILLION	2026	2025	CHANGE	ORGANIC	SCOPE	CURRENCY
Q3 revenue	591.0	543.7	+8.7%	+5.1%	+0.8%	+2.8%
9M revenue	1,701.0	1,659.6	+2.5%	+3.9%	(0.3)%	(1.1)%

Sequential improvement in organic growth continued in the Industrials & Commodities division. Organic growth in the third quarter of 2026 reached 5.1%, and it grew 3.9% in the last nine months.

• Energy & Industrial Assets (51% of divisional revenue)

The Product Line delivered low-single-digit organic revenue growth in the third quarter of 2026. Performance was primarily supported by sustained spend on new projects with Oil & Gas Capex-activities recording double-digit organic growth. High commodity prices are driving operators to delay major Opex activities, including maintenance shutdowns, as they maintain production while managing risks. For other sources of energy, projects investments continued to flow for grids and power generation with Power & Utilities Capex spend achieving solid growth.

• Commodities (24% of divisional revenue)

The Commodities Product Line delivered high-single-digit organic revenue growth in the third quarter of 2026, with Metals & Minerals driving growth. This was supported by sustained mining spend, the progressive ramp-up of major contracts and higher demand for upstream mineral testing services.

• Marine & Offshore (25% of divisional revenue)

The Marine & Offshore Product Line delivered high-single-digit organic revenue growth in the third quarter of 2026. Capex activities maintained strong double-digit momentum, supported by the continued conversion of a solid backlog across new vessel classification and equipment certification services. Growth in Opex services remained moderate, reflecting the continued impact from the previously announced exit from non-core consulting services.

As of September 30, 2026, the Company secured 11.3 million gross tons of new orders, bringing the order backlog to a record 36.3 million gross tons, up 13.4% year on year and providing strong visibility on future activity.

BUILDINGS & INFRASTRUCTURE

IN EUR MILLION	2026	2025	CHANGE	ORGANIC	SCOPE	CURRENCY
Q3 revenue	562.3	494.3	+13.7%	+7.9%	+4.2%	+1.6%
9M revenue	1,588.4	1,455.1	+9.2%	+8.5%	+1.5%	(0.8)%

Buildings & Infrastructure remained one of the Company’s strongest-performing divisions in the third quarter of 2026, delivering 7.9% organic growth against demanding comparables. In the first nine months, the division grew 8.5% organically.

This performance confirms the strategic priorities of this division.

• Buildings (82% of divisional revenue)

The Buildings Product Line delivered high-single-digit organic revenue growth during the quarter. The performance was primarily fueled by Capex activities, growing broadly across the World, with the exception of the Middle East that is impacted by the ongoing conflict. Mission Critical Assets continues to grow in multiple countries, delivering over 40% on an organic basis, with particularly strong momentum from commissioning activities. The secured backlog provides good visibility over the next two to three years with the ongoing projects immune to the latest local restrictions on permitting and energy access in the United States.

Buildings Opex delivered moderate growth with resilient fundamentals as the bulk of the activity revolves around recurring safety regulatory activities. The predominant regulatory French business is growing healthily, offset by unfavorable comparables from exceptional energy efficiency projects in the third quarter of 2025. The Western hemisphere is showing strong growth as tighter building safety regulations increase and commercial real-estate transaction accelerate.

• Infrastructure activities (18% of divisional revenue)

The Infrastructure Product Line delivered mid-single-digit organic revenue growth in the third quarter, supported by a broader, more diversified portfolio as a result of multiple acquisitions completed in the last three years.

Opex activities maintained strong momentum, supported by recurring asset-integrity and monitoring programs in Italy and transport-related assets in Asia Pacific.

Capex activities grew moderately, reflecting the existing pipeline of projects’ timeline in different geographies.

BUSINESS ASSURANCE

IN EUR MILLION	2026	2025	CHANGE	ORGANIC	SCOPE	CURRENCY
Q3 revenue	137.4	131.6	+4.4%	+3.2%	+0.1%	+1.1%
9M revenue	423.0	415.2	+1.9%	+2.3%	+0.5%	(0.9)%

The Business Assurance division achieved 3.2% organic growth in the third quarter of 2026, a sequential acceleration from the second quarter. In the first 9 months the growth achieved 2.3% organically.

• Certification Solutions (92% of divisional revenue)

The Product Line grew mid-single digit organically, with resilient demand for customized assurance solutions and transition-related programs supporting customers’ operational transformation and supply chain resilience initiatives.

Sustainability services continue to drive growth. Carbon & Environmental services delivered particularly strong growth, while demand for supply chain and advisory services remained buoyant.

The Product Line continues to expand services for new specialized schemes. During the quarter, a CBAM (Carbon Border Adjustment Mechanism) global accreditation was secured. This accreditation helps clients meet evolving EU requirements with reliable and transparent emissions data. This new scheme reinforces the Company position as a trusted partner for carbon compliance.

• Digital Assurance (8% of divisional revenue)

The Product Line recorded a low-single-digit contraction in the third quarter as its service portfolio continued to evolve.

Client demand for Cybersecurity and AI Assurance services is increasing, creating a high-growth market. As this remains a nascent business for Bureau Veritas, the Company is developing its offering and expanding its geographical presence.

The Product Line is rapidly adapting its services and capabilities while integrating its completed acquisitions. This market is being reshaped by evolving client needs and technology new capabilities.

Third-quarter performance continued to reflect these changes, including the non-renewal of a consulting-type offensive cybersecurity contract. This impact will end by year-end 2026. Excluding this contract, the Product Line grew double-digit supported by high demand for Operational Technology (OT) and IoT activities.

PRODUCT TESTING & SERVICES

IN EUR MILLION	2026	2025	CHANGE	ORGANIC	SCOPE	CURRENCY
Q3 revenue	279.0	255.6	+9.2%	+7.0%	+0.2%	+2.0%
9M revenue	801.4	772.9	+3.7%	+6.1%	(0.1)%	(2.3)%

The Product Testing & Services division reported a strong 7.0% organic growth in the third quarter of 2026, compared with 6.1% over the first nine months. Growth was broad-based across all three Product Lines.

• Consumer (54% of divisional revenue)

The Consumer Product Line delivered mid-single digit organic revenue growth in the quarter. Testing activities were accretive to the Product Line organic growth, carried by higher volumes in South Asia and a sourcing shift back to China. Supply Chain & Sustainability services improved, supported by demand for supply-chain resilience and responsible sourcing solutions.

• Technology services (24% of divisional revenue)

The Technology Product Line delivered double-digit organic revenue growth in the quarter. The diversification strategy and the acquisitions completed in the last two years contributed to this strong growth. Growth acceleration in Electronics is supported by the renewal of AI-enabled laptops, desktops and connected devices, as well as increasing local testing requirements for market access. Growth was also robust in the key markets of Japan and Brazil, where new regulations supported laboratory testing.

• Industrial Product Certification (22% of divisional revenue)

Industrial Product Certification delivered strong high-single-digit organic growth in the quarter. The base business of pressure vessels and welding services continued to grow on par with the Product Line, while Rail and mobility growth in Europe is accretive to the Product Line growth. The North America reindustrialization and investment in gigafactories, semiconductor facilities and data center is driving demand for Machinery certification and automated systems services.

PRESENTATION

• Q3 2026 revenue will be presented on Wednesday, October 21, 2026, at 3:00 p.m. (Paris time)
• A video conference will be webcast live. Please connect to: Link to video conference
• The presentation slides will be available on: https://company.bureauveritas.com/investors/financial-information/financial-results
• All supporting documents will be available on the website
• Live dial-in: Link to conference call

2026 & 2027 FINANCIAL CALENDAR

• FY 2026 Results: February 25, 2027 (before market)
• Q1 2027 Revenue: April 22, 2027 (before market)
• H1 2027 Results: July 27, 2027 (before market)
• Q3 2027 Revenue: October 21, 2027 (before market)

ABOUT BUREAU VERITAS

Bureau Veritas is a world leader in inspection, Business Assurance, and laboratory testing services with a powerful purpose: to shape a world of trust by ensuring responsible progress. With a vision to be the preferred partner for customers’ excellence and sustainability, the Company innovates to help them navigate change.
Created in 1828, Bureau Veritas’ 82,000 employees deliver services in 140 countries. The Company’s technical experts support customers to address challenges in quality, health and safety, environmental protection, and sustainability.
Bureau Veritas is listed on Euronext Paris and belongs to the CAC 40, CAC 40 ESG, SBF 120 indices and is part of the CAC SBT 1.5° index. Compartment A, ISIN code FR 0006174348, stock symbol: BVI.
For more information, visit www.bureauveritas.com, and follow us on LinkedIn.

	Our information is certified with blockchain technology. Check that this press release is genuine at www.wiztrust.com.
ANALYST/INVESTOR CONTACTS			MEDIA CONTACTS
Laurent Brunelle			Karine Havas
+33 (0) 7 79 52 69 21			+33 (0) 6 68 63 83 18
laurent.brunelle@bureauveritas.com			karine.havas@bureauveritas.com
Colin Verbrugghe			Frédéric Vallois
+33 (0) 6 80 53 26 72			+33 (0) 6 21 66 31 04
colin.verbrugghe@bureauveritas.com			frederic.vallois@bureauveritas.com
Romain Gorge romain.gorge@bureauveritas.com Inès Lagoutte ines.lagoutte@bureauveritas.com

This press release (including the appendices) contains forward-looking statements, which are based on current plans and forecasts of Bureau Veritas’ management. Such forward-looking statements are by their nature subject to a number of important risk and uncertainty factors such as those described in the Universal Registration Document (“Document d’enregistrement universel”) filed by Bureau Veritas with the French Financial Markets Authority (“AMF”) that could cause actual results to differ from the plans, objectives and expectations expressed in such forward-looking statements. These forward-looking statements speak only as of the date on which they are made, and Bureau Veritas undertakes no obligation to update or revise any of them, whether as a result of new information, future events or otherwise, according to applicable regulations.

APPENDIX 1: REVENUE BY BUSINESS

			Q3/9M GROWTH
IN EUR MILLION	Q3 / 9M 2026	Q3 / 9M 2025	CHANGE	ORGANIC	SCOPE	CURRENCY
Industrials & Commodities	591.0	543.7	+8.7%	+5.1%	+0.8%	+2.8%
Buildings & Infrastructure	562.3	494.3	+13.7%	+7.9%	+4.2%	+1.6%
Business Assurance	137.4	131.6	+4.4%	+3.2%	+0.1%	+1.1%
Product Testing & Services	279.0	255.6	+9.2%	+7.0%	+0.2%	+2.0%
Total Q3 revenue	1 569.7	1 425.2	+10.1%	+6.2%	+1.8%	+2.1%
Industrials & Commodities	1,701.0	1,659.6	+2.5%	+3.9%	(0.3)%	(1.1)%
Buildings & Infrastructure	1,588.4	1,455.1	+9.2%	+8.5%	+1.5%	(0.8)%
Business Assurance	423.0	415.2	+1.9%	+2.3%	+0.5%	(0.9)%
Product Testing & Services	801.4	772.9	+3.7%	+6.1%	(0.1)%	(2.3)%
Total 9M revenue	4,513.8	4,302.8	+4.9%	+5.7%	+0.4%	-1.2%

			Q2 GROWTH
IN EUR MILLION	Q2 2026	Q2 2025	CHANGE	ORGANIC	SCOPE	CURRENCY
Industrials & Commodities	577.4	562.0	+2,7%	+3.5%	(0.5)%	(0.3)%
Buildings & Infrastructure	529.9	484.6	+9.4%	+10.2%	(0.6)%	(0.2)%
Business Assurance	151.7	149.5	+1.5%	+1.5%	+0.6%	(0.6)%
Product Testing & Services	291.6	280.2	+4.1%	+6.1%	+0.1%	(2.1)%
Total Q2 revenue	1,550.6	1,476.3	+5.0%	+5.9%	(0.3)%	(0.6)%

			Q1 GROWTH
IN EUR MILLION	Q1 2026	Q1 2025	CHANGE	ORGANIC	SCOPE	CURRENCY
Industrials & Commodities	532.6	553.9	(3.9)%	+3.1%	(1.1)%	(5.9)%
Buildings & Infrastructure	496.2	476.2	+4.2%	+7.3%	+0.9%	(4.0)%
Business Assurance	133.9	134.1	(0.1)%	+2.3%	+0.7%	(3.1)%
Product Testing & Services	230.8	237.1	(2.7)%	+5.1%	(0.6)%	(7.2)%
Total Q1 revenue	1,393.5	1,401.3	(0.6)%	+4.8%	(0.1)%	(5.3)%

APPENDIX 2: 2026 AND 2025 REVENUE BY QUARTER

	2026 REVENUE BY QUARTER
IN EUR MILLION	Q1 2026	Q2 2026	Q3 2026
Industrials & Commodities	532.6	577.4	591.0
Buildings & Infrastructure	496.2	529.9	562.3
Business Assurance	133.9	151.7	137.4
Product Testing & Services	230.8	291.6	279.0
Total revenue	1 393.5	1 550.6	1 569.7

	2025 REVENUE BY QUARTER
IN EUR MILLION	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Industrials & Commodities	553.9	562.0	543.7	565.6
Buildings & Infrastructure	476.2	484.6	494.3	540.6
Business Assurance	134.1	149.5	131.6	156.5
Product Testing & Services	237.1	280.2	255.6	264.8
Total revenue	1,401.3	1,476.3	1 425.2	1 527.5

APPENDIX 3: DEFINITION OF ALTERNATIVE PERFORMANCE INDICATORS AND RECONCILIATION WITH IFRS

The management process used by Bureau Veritas is based on a series of alternative performance indicators, as presented below. These indicators were defined for the purposes of preparing the Company’s budgets and internal and external reporting. Bureau Veritas considers that these indicators provide additional useful information to financial statement users, enabling them to better understand the Company’s performance, especially its operating performance. Some of these indicators represent benchmarks in the testing, inspection and Business Assurance (“TIC”) business and are commonly used and tracked by the financial community. These alternative performance indicators should be seen as complementary to IFRS-compliant indicators and the resulting changes.

GROWTH

Total revenue growth

The total revenue growth percentage measures changes in consolidated revenue between the previous year and the current year. Total revenue growth has three components:

• Organic growth,
• Impact of changes in the scope of consolidation (scope effect),
• Impact of changes in exchange rates (currency effect).

Organic growth

The Company internally monitors and publishes “organic” revenue growth, which it considers to be more representative of the Company’s operating performance in each of its business sectors.

The main measure used to manage and track consolidated revenue growth is like-for-like, also known as organic growth. Determining organic growth enables the Company to monitor trends in its business excluding the impact of currency fluctuations, which are outside of Bureau Veritas’ control, as well as scope effects which concern new businesses or businesses that no longer form part of the business portfolio. Organic growth is used to monitor the Company’s performance internally.

Bureau Veritas considers that organic growth provides management and investors with a more comprehensive understanding of its underlying operating performance and current business trends, excluding the impact of acquisitions, divestments (outright divestments as well as the unplanned suspension of operations – in the event of international sanctions, for example) and changes in exchange rates for businesses exposed to foreign exchange volatility, which can mask underlying trends.

The Company also considers that separately presenting organic revenue generated by its businesses provides management and investors with useful information on trends in its industrial businesses and enables a more direct comparison with other companies in its industry.

Organic revenue growth represents the percentage of revenue growth, presented at Group level and for each business, based on a constant scope of consolidation and exchange rates over comparable periods:

• Constant scope of consolidation: data are restated for the impact of changes in the scope of consolidation over a 12-month period,
• Constant exchange rates: data for the current year are restated using exchange rates for the previous year.

Scope effect

To establish a meaningful comparison between reporting periods, the impact of changes in the scope of consolidation is determined:

• For acquisitions carried out in the current year: by deducting from revenue for the current year revenue generated by the acquired businesses in the current year,
• For acquisitions carried out in the previous year: by deducting from revenue for the current year revenue generated by the acquired businesses in the months in the previous year in which they were not consolidated,
• For disposals and divestments carried out in the current year: by deducting from revenue for the previous year revenue generated by the disposed and divested businesses in the previous year in the months of the current year in which they were not part of the Company,
• For disposals and divestments carried out in the previous year: by deducting from revenue for the previous year revenue generated by the disposed and divested businesses in the previous year prior to their disposal/divestment.

Currency effect

The currency effect is calculated by translating revenue for the current year at the exchange rates for the previous year.

---

¹ Alternative performance indicators are presented, defined and reconciled with IFRS in appendix 3 of this press release.
² As per IFRS 5, excluding the activities planned for exit (Oil & Petrochemicals and Coal Testing and Inspection and from the “Government Services” businesses)

³ Scope 1 and Scope 2 greenhouse gas emissions are calculated over a 12-month rolling period. The most recent quarter is estimated based on the corresponding quarter from the previous year.

⁴ TAR: Total Accident Rate (number of accidents with and without lost time x 200,000/number of hours worked).

⁵ Proportion of women from the Executive Committee to Band II (internal grade corresponding to a management or executive management position) in the Company (number of women on a full-time equivalent basis in a leadership position/total number of full-time equivalents in leadership positions).

⁶ Indicator calculated over a 12-month rolling period.

⁷ As per IFRS 5, excluding the activities planned for exit (Oil & Petrochemicals and Coal Testing and Inspection and from the “Government Services” businesses)

⁸ At constant currency
⁹ (Net cash generated from operating activities – lease payments + income tax) / adjusted operating profit
¹⁰ After-tax Adjusted Operating Profit / (Equity excluding assets & liabilities held for sale + Net Debt excluding lease)

Attachment

• 2026 10 21_Press Release_Q3 2026 Revenue vDEF

Fouad Azzam is a Partner with EQT Life Sciences, bringing extensive experience investing in and supporting fast-growing medical technology and life sciences companies

EINDHOVEN, the Netherlands, Oct. 21, 2026 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD – US OTCQX: ONWRY), the neurotechnology company pioneering spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities, today announced the appointment of Fouad Azzam as a non-executive member of its Board of Directors.

“We are pleased to welcome Fouad Azzam to our Board of Directors,” said Dave Marver, CEO of ONWARD Medical. “His deep experience supporting growth-stage medical device companies is highly relevant as we scale our business and pursue our important mission to help people living with spinal cord injuries and other movement disabilities.”

“ONWARD combines breakthrough science, a high potential business opportunity, and a clear path to make a meaningful impact for people living with paralysis,” said Fouad Azzam. “I look forward to supporting the ONWARD team as they expand access to the ARC-EX^® System and advance the broader pipeline, which includes groundbreaking implantable spinal cord stimulation and brain-computer interface technologies.”

Fouad is a Partner in the EQT Life Sciences team. Before joining EQT, he served as Managing Director of Eastman Ventures and as a Director at Eastman Chemical Company, where he held various roles spanning strategy, new business development, and corporate development. Earlier in his career, he worked in the Research and Business Development group at Occidental Chemical Company. He currently serves on the Boards of Directors for several biotechnology and medical technology companies, including Neuros Medical, Shinobi Therapeutics, HotSpot Therapeutics, and Xycolor Therapeutics. He previously served on the Boards of multiple medical technology companies including Cardiac Dimensions, Endotronix, and Simplify Medical.

Fouad holds a PhD in Chemical Engineering from the University of Akron and an MBA from the State University of New York at Buffalo.

About ONWARD Medical

ONWARD Medical is the neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities. Building on decades of scientific discovery, preclinical research, and clinical studies conducted at leading hospitals, rehabilitation clinics, and neuroscience laboratories, the Company developed the ARC Therapy. It has subsequently been awarded 10 Breakthrough Device Designations from the FDA. The Company’s ARC EX^® System is cleared for commercial sale in the US and Europe. The Company is also developing an investigational implantable system called ARC-IM^®, designed to address several unmet needs including blood pressure instability after spinal cord injury. It can also be paired with a brain-computer interface (BCI) and artificial intelligence (AI) to restore thought-driven movement.

Headquartered in the Netherlands, the Company has a Science and Engineering Center in Switzerland and a US office in Boston, Massachusetts. The Company is listed on Euronext Paris, Brussels, and Amsterdam (ticker: ONWD) and its US ADRs can be traded on OTCQX (ticker: ONWRY).

To learn more about ONWARD Medical’s commitment to partnering with the spinal cord injury community to develop innovative solutions for restoring movement, function, and independence after spinal cord injury, please visit ONWD.com.

To be kept informed about the Company’s technologies, research studies, and the availability of therapies in your area, please complete this webform.

For Media Inquiries:
Sébastien Cros, VP Communications
media@onwd.com  

For Investor Inquiries:
investors@onwd.com

Disclaimer  

Certain statements, beliefs, and opinions in this press release are forward-looking, which reflect the Company’s or, as appropriate, the Company directors’ current expectations and projections about future events. By their nature, forward-looking statements involve several risks, uncertainties, and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, delays in regulatory approvals, changes in demand, competition, and technology, can cause actual events, performance, or results to differ significantly from any anticipated development. Forward-looking statements contained in this press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. As a result, the Company expressly disclaims any obligation or undertaking to release any update or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions, or circumstances on which these forward-looking statements are based. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Trademarks: ONWARD, ARC-EX, ARC-IM, ARC-BCI, and the stylized O-Logo are proprietary and registered trademarks of ONWARD Medical. Unauthorized use is strictly prohibited.

Investigational Products: ARC-IM and ARC-BCI are investigational and not available for commercial use. ARC-IM is limited by United States law to investigational use.